Searched by
Class I
| Clip | Code No. | Product | Data | |||
|---|---|---|---|---|---|---|
| Data
Sheet |
Category | Conjugate | MHC Allele | Size | Availability | |
| Sequence | Location (aa) | Storage
temp. |
||||
|
|
||||||
|
TS-M270-1 |
HLA-B*07:02 KIF16B Neoepitope Tetramer-APARLERRHSA-PE |
|
|||
|
cancer | PE | B*07:02 | 50 tests |
0 (Contact us) |
|
| APARLERRHSA | 4°C | |||||
|
TS-M235-2 |
HLA-A*02:01 Filamin-A Neoepitope Tetramer-HIAKSLFEV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| HIAKSLFEV | 4°C | |||||
|
TS-M231-2 |
HLA-A*02:01 GNL3L Neoepitope Tetramer-NLNCCSVPV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| NLNCCSVPV | 4°C | |||||
|
TS-M231-1 |
HLA-A*02:01 GNL3L Neoepitope Tetramer-NLNCCSVPV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| NLNCCSVPV | 4°C | |||||
|
TS-M207-1 |
HLA-A*02:01 CDK4 Neoepitope Tetramer-ALDPHSGHFV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALDPHSGHFV | 4°C | |||||
|
TC-8029-1 |
HLA-A*03:01 KRAS8-16 G12C Tetramer-VVGACGVGK-PE |
|
|||
|
cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| VVGACGVGK | 8-16 | 4°C | ||||
|
TS-M611-2 |
H-2Kb β-catenin Tetramer-RTYTYEKL-APC |
|
|||
|
Others | APC | H-2Kb | 50 tests |
0 (Contact us) |
|
| RTYTYEKL | 329-336 | 4°C | ||||
|
TC-8008-1 |
HLA-A*02:01 HPV29-38 Tetramer-TIHDIILECV-PE |
|
|||
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| TIHDIILECV | 29-38 | 4°C | ||||
|
TS-M206-2 |
HLA-A*02:01 HCV polyprotein Tetramer-LLFNILGGWV-APC |
|
|||
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLFNILGGWV | 1807-1816 | 4°C | ||||
|
TC-8019-1 |
HLA-A*02:01 MAGE-A2112-120 Tetramer-KMVELVHFL-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KMVELVHFL | 112-120 | 4°C | ||||
|
TS-M266-1 |
HLA-A*24:02 COASY Neoepitope Tetramer-RFLEYLPLRF-PE |
|
|||
|
cancer | PE | A*24:02 | 50 tests |
0 (Contact us) |
|
| RFLEYLPLRF | 4°C | |||||
|
TS-M229-1 |
HLA-A*02:01 SNX24 Neoepitope Tetramer-KLSHQLVLL-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLSHQLVLL | 4°C | |||||
|
TC-8007-1 |
HLA-A*02:01 P53168-176 Tetramer-HMTEVVRRC-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| HMTEVVRRC | 168-176 | 4°C | ||||
|
TS-M268-1 |
HLA-A*24:02 p53 Tetramer-TYSPALNKMF-PE |
|
|||
|
cancer | PE | A*24:02 | 50 tests |
0 (Contact us) |
|
| TYSPALNKMF | 125-134 | 4°C | ||||
|
TS-M236-2 |
HLA-A*02:01 PGM5 Neoepitope Tetramer-QQFAVGSYV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| QQFAVGSYV | 4°C | |||||
|
TS-M225-2 |
HLA-A*02:01 Hsp70 Neoepitope Tetramer-SLFEGIDIYT-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLFEGIDIYT | 4°C | |||||
|
TS-M249-1 |
HLA-A*02:01 APOL1 Tetramer-ALADGVQKV-PE |
|
|||
|
Others | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALADGVQKV | 192-200 | 4°C | ||||
|
TS-M223-2 |
HLA-A*02:01 TEF-1 Neoepitope Tetramer-VLENFTIFLV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLENFTIFLV | 4°C | |||||
|
TS-M207-2 |
HLA-A*02:01 CDK4 Neoepitope Tetramer-ALDPHSGHFV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALDPHSGHFV | 4°C | |||||
|
TS-M265-1 |
HLA-A*24:02 β-catenin Neoepitope Tetramer-SYLDSGIHF-PE |
|
|||
|
cancer | PE | A*24:02 | 50 tests |
0 (Contact us) |
|
| SYLDSGIHF | 4°C | |||||
|
TS-M224-1 |
HLA-A*02:01 CDC37L1 Neoepitope Tetramer-FLSDHLYLV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLSDHLYLV | 4°C | |||||
|
TS-M212-1 |
HLA-A*02:01 CLPP Neoepitope Tetramer-ILDKVLVHL-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILDKVLVHL | 4°C | |||||
|
TS-M238-2 |
HLA-A*02:01 SNAT1 Neoepitope Tetramer-ILAALFLGL-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILAALFLGL | 4°C | |||||
|
TS-M219-1 |
HLA-A*02:01 SMARCD3 Neoepitope Tetramer-KLFEFLVYGV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLFEFLVYGV | 4°C | |||||
|
TS-M608-2 |
H-2Kb MCMV M139 Tetramer-TVYGFCLL-APC |
|
|||
|
virus | APC | H-2Kb | 50 tests |
0 (Contact us) |
|
| TVYGFCLL | 419-426 | 4°C | ||||
|
TS-M215-1 |
HLA-A*02:01 WDR46 Neoepitope Tetramer-FLIYLDVSV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLIYLDVSV | 4°C | |||||
|
TC-8018-2 |
HLA-A*02:01 HBV194-202 Tetramer-FLLTKILTI-APC |
|
|||
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLLTKILTI | 194-202 | 4°C | ||||
|
TS-M620-2 |
H-2Kb YPEL3 Tetramer-RAYLFNSV-APC |
|
|||
|
Others | APC | H-2Kb | 50 tests |
0 (Contact us) |
|
| RAYLFNSV | 47-54 | 4°C | ||||
|
TS-M218-2 |
HLA-A*02:01 ACTN1 Neoepitpe Tetramer-FIASNGVKLV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| FIASNGVKLV | 4°C | |||||
|
TS-M273-1 |
HLA-B*07:02 TTBK2 Neoepitope Tetramer-RPHHDQRSL-PE |
|
|||
|
cancer | PE | B*07:02 | 50 tests |
0 (Contact us) |
|
| RPHHDQRSL | 4°C | |||||
|
TS-M272-2 |
HLA-B*07:02 MLL3 Neoepitope Tetramer-KPSDTPRPVM-APC |
|
|||
|
cancer | APC | B*07:02 | 50 tests |
0 (Contact us) |
|
| KPSDTPRPVM | 4°C | |||||
|
TS-M214-1 |
HLA-A*02:01 COL18A1 Neoepitope Tetramer-VLLGVKLFGV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLLGVKLFGV | 4°C | |||||
|
TC-8024-2 |
HLA-A*02:01 KRAS5-14 WT Tetramer-KLVVVGAGGV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLVVVGAGGV | 5-14 | 4°C | ||||
|
TS-M228-2 |
HLA-A*02:01 PGML5 Neoepitope Tetramer-AVGSYVYSV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| AVGSYVYSV | 4°C | |||||
|
TS-M227-2 |
HLA-A*02:01 KMT2D Neoepitope Tetramer-ALSPVIPHI-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALSPVIPHI | 4°C | |||||
|
TS-M277-1 |
HLA-B*08:01 FAM50B Neoepitope Tetramer-DMKARQKALV-PE |
|
|||
|
cancer | PE | B*08:01 | 50 tests |
0 (Contact us) |
|
| DMKARQKALV | 4°C | |||||
|
TS-M238-1 |
HLA-A*02:01 SNAT1 Neoepitope Tetramer-ILAALFLGL-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILAALFLGL | 4°C | |||||
|
TS-M261-2 |
HLA-A*11:01 MATN2 Neoepitope Tetramer-KTLTSVFQK-APC |
|
|||
|
cancer | APC | A*11:01 | 50 tests |
0 (Contact us) |
|
| KTLTSVFQK | 4°C | |||||
|
TS-M212-2 |
HLA-A*02:01 CLPP Neoepitope Tetramer-ILDKVLVHL-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILDKVLVHL | 4°C | |||||
|
TS-M209-2 |
HLA-A*02:01 SRPX Neoepitope Tetramer-TLWCSPIKV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| TLWCSPIKV | 4°C | |||||
|
TS-M221-1 |
HLA-A*02:01 GANAB Neoepitope Tetramer-ALYGFVPVL-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALYGFVPVL | 4°C | |||||
|
TS-M220-2 |
HLA-A*02:01 PRDX5 Neoepitope Tetramer-LLLDDLLVSI-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLLDDLLVSI | 4°C | |||||
|
TS-M201-2 |
HLA-A*01:01 TRIP12 Neoepitope Tetramer-PSDTRQMLFY-APC |
|
|||
|
cancer | APC | A*01:01 | 50 tests |
0 (Contact us) |
|
| PSDTRQMLFY | 4°C | |||||
|
TC-8020-2 |
HLA-A*02:01 PSMA663-671 Tetramer-MMNDQLMFL-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| MMNDQLMFL | 663-671 | 4°C | ||||
|
TS-M222-1 |
HLA-A*02:01 NSDHL Neoepitope Tetramer-ILTGLNYEV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILTGLNYEV | 4°C | |||||
|
TS-M605-2 |
H-2Dd MCMC M18 Tetramer-SGPSRGRII-APC |
|
|||
|
virus | APC | H-2Dd | 50 tests |
0 (Contact us) |
|
| SGPSRGRII | 348-356 | 4°C | ||||
|
TS-M620-1 |
H-2Kb YPEL3 Tetramer-RAYLFNSV-PE |
|
|||
|
Others | PE | H-2Kb | 50 tests |
0 (Contact us) |
|
| RAYLFNSV | 47-54 | 4°C | ||||
|
TS-M244-1 |
HLA-A*02:01 FNDC3B Neoepitope Tetramer-VVMSWAPPV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| VVMSWAPPV | 4°C | |||||
|
TS-M240-1 |
HLA-A*02:01 CK1α Neoepitope Tetramer-GLFGDIYLAI-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLFGDIYLAI | 4°C | |||||
|
TS-M206-1 |
HLA-A*02:01 HCV polyprotein Tetramer-LLFNILGGWV-PE |
|
|||
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLFNILGGWV | 1807-1816 | 4°C | ||||
|
TS-M241-2 |
HLA-A*02:01 CK1α Neoepitope Tetramer-GLFGDIYLA-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLFGDIYLA | 4°C | |||||
|
TS-M236-1 |
HLA-A*02:01 PGM5 Neoepitope Tetramer-QQFAVGSYV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| QQFAVGSYV | 4°C | |||||